TIMLOZE Trademark

Trademark Overview


On Wednesday, June 9, 2021, a trademark application was filed for TIMLOZE with the United States Patent and Trademark Office. The USPTO has given the TIMLOZE trademark a serial number of 90764768. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Radius Health, Inc.. The TIMLOZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-re...
timloze

General Information


Serial Number90764768
Word MarkTIMLOZE
Filing DateWednesday, June 9, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRadius Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameRadius Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Saturday, June 12, 2021NEW APPLICATION ENTERED
Monday, August 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 26, 2022ASSIGNED TO EXAMINER
Saturday, February 26, 2022NON-FINAL ACTION WRITTEN
Saturday, February 26, 2022NON-FINAL ACTION E-MAILED
Saturday, February 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023SOU EXTENSION 1 FILED
Wednesday, March 22, 2023SOU EXTENSION 1 GRANTED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 2 FILED
Monday, September 25, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 18, 2024SOU EXTENSION 3 FILED
Monday, March 18, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 4 GRANTED
Friday, September 20, 2024SOU EXTENSION 4 FILED